VANCOUVER, July 17, 2019 /CNW/ - Arthritis Research Canada, the largest clinical arthritis research institution in North America, continues to grow with its newest centre located at McGill University.
Drs. Deborah Da Costa, Michal Abrahamowicz, Susan Bartlett and Marie Hudson will join the new location and bring with them a collective and extensive knowledge of arthritis research.
Dr. Da Costa's area of study focuses on the connection between mental health and chronic illness. Dr. Abrahamowicz' research involves the development of new, flexible statistical methods for survival analyses. Dr. Bartlett has done extensive research on behavioural factors (like exercise, diet and medication adherence) and their impact on health outcomes in patients with inflammatory arthritis. And Dr. Hudson's expertise is systemic autoimmune rheumatic diseases.
"As Arthritis Research Canada celebrates its 20th anniversary, we are excited to open a new centre and welcome scientists with a wide range of research areas to the team," said Scientific Director Dr. John Esdaile. "This expansion strengthens our ability to improve the lives of Canadians with arthritis."
The announcement of the new location comes as three new scientists also join the British Columbia, Alberta and Quebec centres.
Dr. Jackie Whittaker is an expert on sports injury and osteoarthritis prevention and will be based in BC. Dr. Laëtitia Michou will work from the centre in Quebec, focusing on the human genetics of bone and joint diseases. And Dr. Susanne Benseler, a leading paediatric rheumatologist and Arthritis Research Canada's first scientist with a focus on childhood arthritis, will join the Alberta centre.
"Our scientific team is currently engaged in over 75 studies covering the breadth of arthritis," said Dr. Esdaile. "We are proud to further expand our research in the areas of mental health, paediatrics, arthritis prevention and more."
ABOUT ARTHRITIS RESEARCH CANADA:
Arthritis Research Canada is the largest clinical arthritis research institution in North America. Our mission is to transform the lives of people living with arthritis through research and engagement. Led by world-renowned rheumatologist, Dr. John Esdaile, Arthritis Research Canada's scientific team of over 100 are creating a future where people living with arthritis are empowered to triumph over pain and disability. Within British Columbia, Alberta and Quebec, Arthritis Research Canada is leading research aimed at arthritis prevention, early diagnosis and treatment, and quality of life issues.
SOURCE Arthritis Research Canada
Tried. True. Totally Improved.
Meet the New BlenderBottle® Classic™ Shaker
Lehi, Utah (July 17, 2019) – Innovation never ceases at BlenderBottle®, the brand that revolutionized the portable mixer market. The latest product to join the BlenderBottle shaker lineup is an impressive overhaul to the original BlenderBottle® Classic™ shaker, with features engineered for weekend warriors and elite athletes alike.
BlenderBottle® transformed the health and fitness industry in 2000 with the introduction of the BlenderBall® wire whisk. The original BlenderBottle® Classic™ shaker followed in 2004, quickly becoming a global icon of health and fitness—a status it enjoys to this day. The improvements to the tried and true Classic™ shaker include performance-focused innovation and also modern style.
“The Classic is our cornerstone shaker bottle,” says Michael Sorensen, Vice President of Marketing at BlenderBottle®. “But we have a hard time just resting on our laurels. We’re always looking for new ways to improve performance—even at our introductory price point.”
The new and improved BlenderBottle® Classic™ shaker sports an updated lid featuring a more ergonomic carry loop and customer-favorite SpoutGuard™ to keep dirty gym fingers off the drinking surface. A rounded base enhances mixing performance and conveniently fits in most cup holders. Modern design elements enhance the bottle’s sleek aesthetic appeal.
In addition to these upgrades, the new Classic™ shaker offers familiar features that loyal BlenderBottle customers have come to know and trust. The patented mixing system uses the BlenderBall wire whisk—found only in BlenderBottle® brand shakers—to deliver smooth protein and nutrition shakes with ease. Integrated with the ergonomic, StayOpen™ flip cap, the bottle’s adjustable carry loop offers portable convenience and a place to attach keys while at the gym. The new Classic shaker is covered by a leak proof guarantee—which backs every BlenderBottle® shaker. Measurement markings are clearly embossed on the bottle’s side, and the durable plastic material is top-rack dishwasher safe and BPA and phthalate free.
The new BlenderBottle® Classic™ shaker joins the ever-expanding BlenderBottle shaker line, which includes the high-performance BlenderBottle® ProSeries™shakers, the sleek glass BlenderBottle® Mantra™ shaker, and the modern BlenderBottle® Radian™ shaker. Offered in an array of vibrant colors, the new BlenderBottle Classic shaker is available in 20-ounce and 28-ounce capacities and retails for $8.99 and $9.99 respectively.
Founded in 2000, BlenderBottle Company is a privately held manufacturer of premium and innovative products that help simplify everyday life. The company’s patented, revolutionary products were hailed by Good Morning America, Reader’s Digest, Self, the Today Show, Men’s Fitness, and others as some of the “hottest new products” on the market.
Today BlenderBottle® brand products are available in over 90,000 retail locations worldwide, and in over 70,000 retail locations in the U.S. alone, including GNC, Vitamin Shoppe, Vitamin World, Bed Bath & Beyond, Walmart, Target, Rite Aid, Whole Foods, Amazon.com, and online at blenderbottle.com. BlenderBottle Company is located in Lehi, Utah and markets and sells its products to retailers and resellers worldwide. All BlenderBottle brand products are backed by a Customer Satisfaction Guarantee. For additional information, visit blenderbottle.com.
A brighter future is possible with the launch of The Baker Centre for Pancreatic Cancer
LONDON, ON, July 17, 2019 /CNW/ - On Wednesday, July 17, 2019, London Health Sciences Foundation (LHSF) is launching The Baker Centre for Pancreatic Cancer at London Health Sciences Centre (LHSC) following a donation of $1.5M from Rick and Shelley Baker. The newly created Baker Centre will result in improved access to care, more targeted personalized treatment and new treatment options for pancreatic cancer patients.
"It is with the help of inspirational donors like Rick and Shelley Baker that a change in medical care for pancreatic cancer patients is possible now and into the future," said John MacFarlane, President and CEO at LHSF. This gift will not only impact the lives of pancreatic cancer patients in our community, but in communities around the world."
Pancreatic cancer is a fast growing cancer with one of the lowest survival rates. Diagnosis and treatment is complex with frequent delays and often not detected until at an advanced stage, making treatment more difficult. The Baker Centre for Pancreatic Cancer will be a centre of excellence in pancreatic care and research. The centre will offer a multidisciplinary clinic, new diagnostic technology, streamlined process for patients and the development of a new Translational Pancreatic Research Program. In addition to the clinical and research areas of The Baker Centre for Pancreatic Cancer, a focus will be placed on enhancing the utilization of Patient Assistance Funds to support out-of-pocket costs associated with care.
"We need to do better for pancreatic cancer patients in our community. Dr. Stephen Welch and his team were excellent, but the access to cutting edge technology and experimental treatment options was just not there," said Rick Baker, grateful patient and donor. "I had to travel the world to find alternative treatments and trials to help me fight this disease. I want to help others, here in London, to have access to better treatment options and technology. With Dr. Welch and the medical experts at London Health Sciences Centre and the philanthropic support of London Health Sciences Foundation we can create possibilities for patients that didn't exist before."
The Baker Centre for Pancreatic Cancer will service patients from London and communities across Southwestern Ontario. It will provide quicker and more coordinated access to care as well as enhanced diagnosis and treatment through new technology. It will also focus on developing new treatment options for the future through an intensive research program.
The Baker Centre for Pancreatic Cancer will develop a database to track and measure patient outcomes, purchase an Endoscopic Ultrasound machine, begin genomic sequencing for all newly diagnosed patients, raise awareness for the Patient Assistance Funds, officially launch the Translational Pancreatic Research Program and establish a dedicated fund for pancreatic cancer research within the existing Catalyst Grant Program.
About London Health Sciences Foundation (LHSF) is a Canada Revenue Agency registered charity accredited by both Imagine Canada and the Better Business Bureau, linking our community and health care experts - including physicians, allied professionals, researchers, staff and educators - together in pursuit of medical excellence at London Health Sciences Centre (LHSC) and Lawson Health Research Institute (Lawson). Established to strengthen LHSC's ability to provide the highest quality health care for patients in Southwestern Ontario and beyond, LHSF offers opportunities to support discovery and innovation in research, education and patient care at our hospital. To see how donations enable extraordinary care, visit www.lhsf.ca.
SOURCE London Health Sciences Foundation
CBD ESSENTIALS SUPPORTS CHRISTINE CLINTON CANCER CARE DURING BREAST CANCER AWARENESS MONTH
“Therapy Designed by Nature”
Topically Applied Farm-to-Skin CBD Featuring the Brand’s Award-Winning ProductsLOS ANGELES, CALIF. (October 2019)—During Breast Cancer Awareness Month, Cannaisseur Brands will donate one 1 oz bottle of oncology massage oil ($29 value) for every Deluxe CBD Essentials First Aid Kit (MSRP $125) sold during the month of October to Christine Clinton Cancer Care to be used for treating clients living with cancer and spa professionals in training. A graduate of Harvard’s “Mind Body Medicine” program, Clinton was trained in medical massage for cancer patients at Memorial Sloan Kettering 17 years ago. Today, Christine’s organization continues to train therapists in the art and science of massage and skincare for clients with compromised health. CBD Essentials was founded by industry expert and advocate Aryn Sieber, who consults with physicians and patients nationwide on the responsible use and medicinal benefits of cannabis. Sieber became a sought-after professional leader in the industry after using cannabis during his own battle with Stage IV cancer.
“It has been a challenge to build awareness of the need for evidence-based, quality education in the field of medical massage,” said Christine Clinton, Founder of Christine Clinton Cancer Care. “There was a time when massage for cancer patients wasn’t encouraged. But we now understand the importance of touch in the healing journey of cancer patients. It has been an honor to be a part of that process, as we continue to train spa professionals globally in this modality.”
CBD Essentials topically applied products are lab-formulated, third-party tested, and batch numbered to ensure quality and consistency. All CBD Essentials products feature Sieber’s award-winning flower and meet the federal requirements of the 2018 Farm Bill, which mandates that all CBD-infused products are derived from dried Cannabis Sativa L. plant material that contains less than 0.3 percent THC to be legal in the United States. (It is important to note that therapeutic statements for CBD products are not yet evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.)
“The benefits of touch cannot be understated in supporting the specific needs of cancer patients during their journey through treatment,” said Ayrn Sieber, Founder of Cannaisseur Brands. “I received CBD massages during my battle with Stage IV cancer. And it was one of the most beneficial aspects of my own healing process. Now that I am cancer-free, it’s a blessing for me to have the opportunity to share my journey and some of these benefits with others going through their own battles with this disease.”
The Cannaisseur Brands CBD Essentials Deluxe First Aid Kit that offers 1 oz bottle of oncology massage oil to Christine Clinton Cancer Care during the month October includes: 1.5 oz. Pain Relief Cream (available in Green Tea Cucumber and Natural); 1 oz. CBD Essentials Salt Soak (available in Green Tea Cucumber, Eucalyptus, Lavender and Natural); 1 oz. CBD Essentials Body + Massage Oil (available in Green Tea Cucumber, Peppermint, Eucalyptus, Lavender and Natural); 0.15 oz. CBD Essentials Lip Balm (available in Tropical Punch, Grape, Coconut, Vanilla and Peppermint); and CBD Essentials Transdermal Patch (unscented). The CBD Essentials Deluxe First Aid Kit is offered at a retail price of $125.
About the products featured in the CBD Essentials First Aid Kits:
CBD Essentials Pain Cream — This body cream, formulated to offer pain relief for sore muscles, aching joints, and chronic skin conditions, won the Les Nouvelles Esthétiques & Spa “Best New Product” award in 2018. A therapeutic blend of premium CBD, select terpenes, and organic hydrators such as coconut oil and shea butter facilitate muscle rejuvenation and replenish moisture for dry skin conditions. The product uses 50 mg. per oz. of premium CBD.
CBD Essentials Salt Soak Concentrate —This therapeutic blend of immune-boosting, mineral-rich sea salts, combined with premium CBD and select terpenes was formulated to soothe sore muscles, reduce stress, and induce relaxation. This product won the Les Nouvelles Esthétiques & Spa “Best New Product” award in 2019.
CBD Essentials Body + Massage Oil —This product features organic coconut oil infused with premium CBD to reduce discomfort associated with muscle and joint inflammation. This non-greasy topically applied product helps to rejuvenate tired muscles and aching joints, enhancing recovery and relieving pain. It was formulated to be used for therapeutic and oncology massages, and has been shown help reduce inflammation associated with arthritis, fibromyalgia, tendonitis and psoriasis in hundreds of real-world test cases. Designed for all skin types, the CBD Essentials Body + Massage Oil also can improve dry skin, deeply hydrating for maximum benefit and long-lasting protection.
CBD Essentials Massage Roll-On —This product features the same formulation of CBD Essentials Body + Massage Oil, in the convenience of a roll-on applicator. CBD Essentials Massage Roll-On is available in Green Tea Cucumber, Peppermint, Eucalyptus, Lavender and Natural in sizes 0.3 oz. at a retail price of $12 ; and 3 oz. at a retail price of $70.
CBD Essentials Transdermal Patch —This THC-free time-released product delivers 70 mg. of premium CBD via a 2.5 in. by 3.5 in. waterproof adhesive patch (so it can be worn in the shower and during a workout) and is effective for up to 36 hours.
CBD Essentials Lip Balm —The first lip balm launched by the brand, CBD Essentials Lip Balm is formulated to moisturize the lips from discomfort associated with dryness and deeply hydrate dry skin for maximum benefit and long-lasting protection.
CBD Essentials products are available at CannasseurBrands.com and select spas, wellness centers and specialty retail outlets nationwide.###About Cannaisseur Brands Cannaisseur Brands was launched by cannabis industry advocate Aryn Sieber, who consults with physicians nation-wide on the legal use of medical cannabis and CBD for their patients. Sieber became a sought-after professional leader in the CBD and medical cannabis industry after using medical cannabis and CBD during his own battle with Stage IV cancer. The topically applied products in the Cannaisseur Brand line are lab-formulated, third-party tested, and batch numbered to ensure quality and consistency. All products in the line feature the brand’s award-winning flower.
About Christine Clinton Cancer Care Founder Christine Clinton holds a certification from Harvard in “Mind Body Medicine” and was trained in medical massage at Memorial Sloan Kettering. She has been working with guests living with cancer in a spa setting for 17 years. Her classes are accredited by NCBTMB in the US, By Think Tree in the UK and partially funded by the Irish Government in Ireland. She works with pain management specialists, holistic chiropractors and functional medicine doctors in her private practice of 28 years.
Atlantic WeedBoard.com Presents “Cannabis Diaries” -- Personal Stories Illustrating the Wellness Benefits of CBD --
There has been a lot of celebration lately about the wellness benefits of CBD, but with so much information out there, it’s hard for the average person to sort out what this can actually mean to them and their loved ones. To illustrate some specific ways CBD can heal the body,Atlantic WeedBoard has created a series of original “Cannabis Diaries” videos featuring real people with real health issues sharing their experience of finding relief with CBD.
An exclusive interview posted this week on Atlantic WeedBoard.com gives the first- hand account of Becky, who suffered for years with severe, chronic hives as well as joint pain, anxiety and insomnia. Her health issues were originally jump-started by a bad reaction to antibiotics, and later diagnosed as an autoimmune disorder. After going from doctor to doctor, exploring a variety of treatments and not finding any relief from traditional medicine, she finally found a solution in the anti-inflammatory properties of CBD oil. Within a month, Becky saw a reduction in her symptoms.
“I was surprised to find that CBD had no psychoactive tendencies,” explains Becky. “I knew I didn’t like that feeling and I wasn’t looking for that. CBD has made a huge difference in my life.”
Another “Cannabis Diaries” video on Atlantic WeedBoard.com tells the story of Kathy. After a burst appendix she was seriously ill with sepsis. Following her stay in the hospital she was sent home with opioids but still not getting relief from the pain. She tried cannabis tincture, which not only helped ease her pain and transition her off the pain medication, but also worked to reduce the stress she was experiencing over the frustration of waiting for body to get better.
“Healing is really hard work and it’s hard to be patient with the process,” says Kathy. “Cannabis gave me a lot more patience to contend with how long things were going to take.”
“We want Atlantic WeedBoard to be a place where people turn to for guidance and clarification about CBD,” says Atlantic WeedBoard co-founder Richard Carey. “These shared stories help people understand how CBD may translate into their own lives.”
AtlanticWeedboard.com is a new website that serves as a resource and community for all things cannabis. Atlantic WeedBoard helps guide consumers through the wellness benefits and choices of CBD products, with a focus on organically grown products where the source and quality are clearly defined. One of the unique features of Atlantic WeedBoard is originally produced video interviews that provide detailed insight into the latest developments and benefits of CBD. In addition to “Cannabis Diaries,” other video themes on the site include the “Five Minutes With…” series of interviews with those who are at the forefront of the CBD revolution, and “High Profile” videos on the cannabis industry, dispensaries and farmers.
Atlantic WeedBoard is a newly-formed informational center specifically developed for the emerging cannabis industry. The site is presented in artistic graphics with a fun side to it featuring a boardwalk and Ferris wheel as its signature logo. On a more serious note, Atlantic WeedBoard is a type of “Consumer Reports” of cannabis as it presents products for people and their pets, interviews with the top growers, curates independently tested legal products and offers anecdotal beauty, health and wellness advice for consumers. For more information, visit www.atlanticweedboard.com
Rapid Dose Therapeutics Signs Distribution Agreement for QuickStrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order
BURLINGTON, ON, July 16, 2019 /CNW/ - Rapid Dose Therapeutics Corp. (CSE: DOSE),("RDT") and Ukraine Pharma (the "Company")announced today that they have signed a twelve month distribution agreement (the "Agreement") to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European countries, giving the Company rights to market the Energy, B12, and Sleep QuickStrip™ nutraceutical products to a consumer base of over 200 million people with tremendous buying power.
The Agreement requires a minimum quarterly order of one million of each of RDT's Energy, B12, and Sleep QuickStrips™ and the Company has provided RDT with a signed purchase order for US$2.1 million.
RDT's proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers an Anytime, Anywhere™ product to consumers. Ukraine Pharma expects to distribute QuickStrip™ by the third calendar quarter of 2019.
"This represents the beginning of a growing opportunity for RDT to provide its QuickStrip™ products to people wanting an effective and innovative means of delivering nutraceuticals," said Mark Upsdell, CEO of RDT. "The Agreement with Ukraine Pharma elevates QuickStrip™ as a growing international brand and delivery device to major market consumers, while simultaneously offering health benefits and improving patient outcomes."
"When we were introduced to the QuickStrip™ technology and nutraceutical product line, we knew this will significantly change the way drugs are delivered," said Veronica Burke, CEO of Ukraine Pharma. "The high quality product combined with the innovative delivery system is something we consider is much needed in the numerous Eastern European countries in which we have established relationships. We will begin distribution in Ukraine and expand from there."
About Rapid Dose Therapeutics Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT's QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT's service-based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward- looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of products using the QuickStrip™ product delivery method, express, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT as to future events or results and are believed to be reasonable based on information currently available to them. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Rapid Dose Therapeutics Corp.
FlexITy and George Brown College Announce Healthcare Technology Partnership
Exceptional Education Meets Exceptional Technology: George Brown's Sally Horsfall Eaton School of Nursing to infuse FlexITy technology into its simulation centre
TORONTO, July 16, 2019 /CNW/ - FlexITy Solutions Inc. and George Brown College, Creating Precision Patient Engagement Experience.
FlexITy is evolving their FlexHealth, Powered by FlexITy, taking it from the hospital to the classroom. Through a new partnership, FlexITy will enhance learning opportunities at George Brown's Sally Horsfall Eaton School of Nursing by infusing new technology into the college's nursing simulation centre – the only one in Canada that is accredited by the Society for Simulation in Healthcare. Healthcare technology, like FlexHealth, can offer better patient care and outcomes, but the first step is educating future nurses on the transformative technology that will ultimately support them.
FlexITy, a leader in Canadian healthcare technology, announced as of April 2018, a FlexHealth solution created in partnership with GetWellNetwork to deploy "smart," patient-centric solutions in Canada. FlexITy's relationship with GetWellNetwork, combined with its deep understanding of the technology, security and data privacy needs of healthcare providers, has enabled the award-winning company to deliver a cutting-edge patient engagement solution that is well-positioned for Canadian healthcare. FlexITy also recently announced they were selected by Mackenzie Health to deliver "smart" patient engagement technology at the current Mackenzie Richmond Hill Hospital and Mackenzie Vaughan Hospital when it opens in late 2020. Continuing with the drive for smart hospitals, with the George Brown College partnership, FlexHealth's technology usage shifts from providing better care today, to better training of Canadian healthcare providers of tomorrow.
"FlexITy is working with George Brown to create an accredited course curriculum, and helping to prepare future healthcare practitioners by giving them the tools during their education in a real-world environment," says Peter Stavropoulos, CEO and President, FlexITy. "We understand how important properly trained practitioners are to a healthcare system; our technology supports the important work that they do. By partnering with George Brown College, we're helping make tomorrow's healthcare system better and more sustainable."
As part of the partnership, one of the hospital teaching rooms in George Brown's simulation centre will be enhanced with FlexHealth, allowing for ample teaching and learning opportunities centred around the technology. George Brown faculty will build an accredited course curriculum around the FlexHealth solution, which will be available to other FlexITy customers in the future for both in person and online training. Other partnership benefits include applied research plans, gamification of healthcare training, work integrated learning opportunities for students, as well as a chance for the two organizations to learn and grow together.
"At George Brown's Sally Horsfall Eaton School of Nursing we always want to leverage the latest technology in order to provide the most relevant educational opportunities to our nursing students, so they are prepared to enter the medical field," says Lori Cranson, Dean, Community Services and Health Sciences at George Brown College. "We are committed to providing the best learning experiences possible and adapting our curriculum to reflect industry-wide trends and changes."
What's more, George Brown is taking an interdisciplinary approach, expanding the project to include other areas of the college. It plans to involve its School of Computer Technology to implement and optimize the technology on campus, and is looking at aligning other academic divisions as the partnership unfolds.
"Collaborating with FlexITy provides new opportunities for students and faculty across the college to use state-of-the art technology," adds Cranson. "It will help prepare our students – in nursing and elsewhere – for the rapidly changing workplace and technologies they will encounter after graduation."
Integrated healthcare technologies are only going to become more prevalent, in Canada and globally, as institutions attempt to deliver better medical care, for less. "Canada's healthcare system is among the most respected in the world. FlexHealth, Powered by FlexITy, further extends patient care and patient outcomes," adds Stavropoulos.
About FlexITy and FlexHealth
FlexITy is an award-winning integrator of smart technology and service solutions, built on powerful and digitally advanced secure platforms, and delivered with decades of IoT expertise and services. FlexHealth-Powered by FlexITy, is a suite of patient-centric solutions that integrate interactive mobile applications, secure health IT and data and optimize healthcare management. FlexHealth engages patients and families, empowers clinicians and delivers outcomes that matter.
Toronto's George Brown College has established a reputation for equipping students with the skills, industry experience and credentials to pursue the careers of their choice. The college offers programs from its three campuses located across the downtown core, and provides housing at its student residence, The George, which opened in September 2016. George Brown offers 162 full-time programs and 194 continuing education certificates/designations across a wide variety of professions to a student body of nearly 29,000 (full-time enrolment) students, including 17 per cent international students; and over 67,000 continuing education registrants. Students can earn certificates, diplomas, graduate certificates, apprenticeships and degrees. www.georgebrown.ca
SOURCE FlexITy Solutions Inc.
The Green New Deal: What It Means for Medicine
by: Jane M. Orient, M.D.
The truth has been acknowledged by Alexandria Ocasio Cortez’s own chief of staff, Saikat Chakrabarti The Green New Deal is not primarily about greening the planet or controlling the climate. It’s about socialism, as the people from whom she plagiarized it have said all along. It’s a fundamental transformation of our way of life.
Since everything you do leaves a “carbon footprint,” the GND encompasses literally everything—especially your medical care.
The first question is whether you should be alive at all. In his sensational 1968 book, The Population Bomb, entomologist (insect specialist) Paul Ehrlich predicted that hundreds of millions of people would starve to death in the 1970s. That bomb fizzled, but he still believes that civilization is doomed within decades, as humanity places inexorable burdens on our Planet’s life support systems. The optimum population of the planet is less than 2 billion, he thinks, or 5.6 billion fewer than we have now.
Once you’re here, Ehrlich and his acolytes would apparently tolerate your presence, although the decline in U.S. life expectancy for the third consecutive year would likely be good news. But having children is another matter. The demographic legacy of one person, calculated over the average time for that person’s lineage to die out, is about 6 person-lifetimes in the U.S., with eventual emission of 9,441 tons of carbon dioxide. So, “reproductive health” ideally means no reproduction for most people, and many millennials (and celebrities) seem to embrace that idea. Predictably, unrestricted or even free abortion is an article of faith among Democrat candidates. And the LGBTQ agenda, also favored by all, tends to contribute to the goal of population reduction.
Ironically, politicians still talk about “our children and our grandchildren,” though they may work to assure that many of us don’t have any.
The U.S. health care sector is said to account for around 10 percent of the CO2 generated in the U.S. and thus “could be implicated” in 10 percent (20,000) of the nearly 200,000 premature deaths attributable to air pollution annually in the United States. (There are about 3 million annual deaths in the U.S., and it is impossible to identify even one as being premature because of air pollution; the argument is purely statistical.) Thus, hospitals are supposedly killing people, albeit indirectly, by using carbon-based energy for heating, air conditioning, elevators, lighting, ventilators, etc.
“Social determinants of health” are the trendiest subject in “healthcare reform.” GND prescriptions would profoundly affect those. Diet would be mostly plant-based foods, with meat limited, ultimately to 1 oz per day. Living space would be restricted, some propose to 320 sq ft per person, with no single-family homes allowed except for trailers. Energy efficiency standards would entail restrictions on entry of outside air, without regard to effects on indoor air pollution, including bacteria and viruses. (More than 300 people in a huge Hong Kong apartment building were infected with severe acute respiratory distress syndrome [SARS] because of this.) Transportation would be mostly walking, bicycling, or public transport. Private vehicles, except possibly electric, might be banned entirely, with roads converted to parks and walkways. It is not clear what emergency responders would do. If electricity came mostly from wind and solar it would be scarce, unreliable, and many times more expensive than now. (Already tens of thousands of deaths in the UK are attributed to inability to afford adequate heating, as costs of “renewable” electricity soared.)
The Democratic presidential debates, except for some squabbling over things like alleged racism, were a display of groupthink. Everybody raised a hand in favor of the GND and universal health care. Some are more radical than others; Kamala Harris insists that we have a “climate crisis,” not just “climate change.” What Americans need to know is the gritty detail behind the virtuous-sounding platitudes. How will their choices be constrained? How much will costs go up—for rent, utilities, fuel, food, and, of course, taxes? How will their standard of living be affected? And how will their actual medical care and health—as opposed to their health insurance card—be affected?
###
Jane M. Orient, M.D. obtained her undergraduate degrees in chemistry and mathematics from the University of Arizona in Tucson, and her M.D. from Columbia University College of Physicians and Surgeons in 1974. She completed an internal medicine residency at Parkland Memorial Hospital and University of Arizona Affiliated Hospitals and then became an Instructor at the University of Arizona College of Medicine and a staff physician at the Tucson Veterans Administration Hospital. She has been in solo private practice since 1981 and has served as Executive Director of the Association of American Physicians and Surgeons (AAPS) since 1989. She is currently president of Doctors for Disaster Preparedness. She is the author of YOUR Doctor Is Not In: Healthy Skepticism about National Healthcare, and the second through fifth editions of Sapira's Art and Science of Bedside Diagnosis published by Wolters Kluwer. She authored books for schoolchildren, Professor Klugimkopf’s Old-Fashioned English Grammar and Professor Klugimkopf’s Spelling Method,published by Robinson Books, and coauthored two novels published as Kindle books, Neomorts and Moonshine. More than 100 of her papers have been published in the scientific and popular literature on a variety of subjects including risk assessment, natural and technological hazards and nonhazards, and medical economics and ethics. She is the editor of AAPS News, the Doctors for Disaster Preparedness Newsletter, and Civil Defense Perspectives, and is the managing editor of the Journal of American Physicians and Surgeons.
Do You Know Where Your Cannabis Comes From? This Family-Owned Farm Encourages, Empowers Customers to “Know Thy Source”
Committed to purity, sustainability, Autumn Brands’ sixth-generation Dutch farmers encourage, empower customers to “know thy source”
LOS ANGELES, California – (July 16th, 2019): As consumer awareness and concern rises over the health and environmental impacts of commercial farming, Autumn Brands stands out as a sixth-generation family-run, farm-to-consumer agricultural business. The first to receive a California Provisional Annual Cultivation license in Santa Barbara County, Autumn Brands is a 50% woman-owned company known for its holistic focus and artisanal approach to producing powerfully potent strains of pesticide-free cannabis. Today, the same sustainable farming practices which originated with the Brand family in Holland over a century ago produce the premium, estate-grown cannabis that is reshaping the future of plant medicine.
In an age of expansive, complicated supply chain operations, where consumers must work hard to pinpoint the source of their food or medicine, Autumn Brands encourages and empowers medicinal and recreational cannabis users to “know thy source.” A recent study reports that over 60% of American consumers actively research the source of their food. Concerns about environmental impact as well as personal health benefits are greatly affecting the way consumers think about what goes into their bodies and how it connects to the greater good.
With the meteoric rise of commercially-farmed cannabis, government agencies are working harder than ever to keep up with explosive demand, leaving room for troubling quality control and environmental impact issues. Fortunately, companies like Autumn Brands, committed to both sustainable, quality cultivation practices and production transparency, are making it easier than ever for consumers to know and trust the source of their cannabis.
“We respect cannabis as a powerful earth medicine - one which offers untold benefits to so many people in every walk of life and lifestyle” explains Hans Brand, fifth-generation farmer and co-founder of Autumn Brands, “But with that power comes the responsibility to uphold clean cultivation practices and, above all, source transparency. It’s important for our customers to know what they’re putting in their bodies, and with our premium products, buyers can have peace of mind that they absolutely do.”
Autumn Brands brings an uncompromising work ethic, informed by generations of family farming, to the task of producing hand-selected, sun-grown buds, each hang-dried, hand-trimmed and cured to preserve maximum potency and full healing benefits. Determined to stand out in a fast-growing cannabis industry, the company aims to deliver sustainably sourced, farm-to-consumer cannabis to an eager health and wellness market. Visit www.AutumnBrands.com to learn more and discover their full selection of premium flower, pre-rolls, and pre-filled cartridges. Follow on Instagram @AutumnBrands for new product releases and updates.
About Autumn Brands:
Autumn Brands is a licensed California cannabis cultivator dedicated to the synergy of health and wellness. The Autumn Brands’ family farm started in Holland more than a century ago, and today, sixth-generation farmers apply the same expertise garnered in growing the world’s finest tulips to producing pure and potent strains of cannabis in sunny, coastal Santa Barbara County. Autumn Brands is proud to be 50 percent woman-owned, free of pesticides and other harmful chemicals. For more information, visit www.autumnbrands.com or email leighanne@anderson-pr.com.
Scotiabank, MD Financial Management, and the Canadian Medical Association announce $3.58 million to support family medicine
Five-year sponsorship agreement with the College of Family Physicians of Canada will support students, family medicine residents, family physicians, and recognition of excellence among family doctors in Canada
TORONTO, July 15, 2019 /CNW/ - Today, Scotiabank and MD Financial Management Inc. (MD), in collaboration with the Canadian Medical Association (CMA), are announcing a $3.58 million investment to support professional development for family doctors across the country as well as awards and scholarships for medical students and family medicine residents. Scotiabank and MD have also signed a five-year agreement with the College of Family Physicians of Canada (CFPC) and its Foundation for Advancing Family Medicine (FAFM) to support the next generation of family doctors. Representing nearly half of all physicians in Canada, the CFPC is an important body whose work touches the lives of all Canadians.
The $3.58 million in funding, to be distributed over five years, is the latest in a series of contributions Scotiabank is making to Canada's medical profession as part of its 10-year, $115-million affinity agreement with the CMA. The funds will include annual investments for:
student and family medicine resident scholarships and awards, including funds dedicated to Indigenous students and residents;
the CFPC's Family Medicine Forum, Canada's largest gathering of family physicians for professional development, networking and celebrating the outstanding achievements of family physicians including the Family Physician of the Year awards;
international fellowships in family medicine to support advancing primary care globally; and
family medicine interest groups at medical schools across Canada to inspire students to pursue rewarding careers in family medicine.
The announcement comes just after the CFPC celebrated the anniversary of its founding in June 1954. Leveraging a combined 115 years of experience serving the best interest of physicians, MD, Scotiabank, CFPC and FAFM will work together to explore ways to develop new initiatives to support family physicians in Canada.
"For 50 years, MD has invested in physicians and the issues most important to them and their communities," said Brian Peters, President and CEO of MD Financial Management. "This new sponsorship illustrates our ongoing commitment."
"Scotiabank recognizes the crucial role of family physicians in communities across Canada and is proud to support them through this collaboration with the CFPC, working together to recognize family doctors, provide scholarships to medical students and family medicine residents, and connect the best of family medicine to the international community," said Glen Gowland, Executive Vice President, Global Wealth Management at Scotiabank.
"We are so pleased to support the CFPC through this financial contribution. Family medicine is the backbone of primary care in Canada, and we must seize every opportunity to connect the profession, celebrate its contribution to patient care, and enable professional development," stated Dr. Gigi Osler, CMA President.
"For 65 years and counting, the CFPC remains dedicated to the training, certification and lifelong learning of family doctors," said CFPC President Dr. Paul Sawchuk. "We are very grateful for the generous support from Scotiabank and MD that will help us further enhance this important work, create new opportunities to celebrate outstanding achievements, and encourage a strong future in family medicine for the people in Canada."
About Affinity Contributions Scotiabank, MD Financial Management (MD) and the Canadian Medical Association (CMA) together are firmly committed to supporting the medical profession and advancing health in Canada. As proof of this commitment, and in collaboration with the CMA and MD, Scotiabank will invest $115 million over the next 10 years to support physicians and the communities they serve across Canada. Additional announcements for the physician community are forthcoming, recognizing that such collaborations are essential to support the profession and effect meaningful change.
About Scotiabank Scotiabank is Canada's international bank and a leading financial services provider in the Americas. We are dedicated to helping our more than 25 million customers become better off through a broad range of advice, products and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. With a team of more than 99,000 employees and assets of over $1 trillion (as at April 30, 2019), Scotiabank trades on the Toronto Stock Exchange (TSX: BNS) and New York Stock Exchange (NYSE: BNS). For more information, please visit www.scotiabank.com and follow us on Twitter @ScotiabankViews.
About MD Financial Management Inc. With 50 years of physician-focused experience, MD has one main goal: to help Canada's physicians achieve financial well-being. MD had $50 billion in assets under administration as of July 5, 2019 and is dedicated to serving Canada's physicians and their families. MD provides financial products and services, the MD Family of Funds and investment counselling services through the MD Group of Companies. For a detailed list of these companies, visit md.ca.
About the College of Family Physicians of Canada The College of Family Physicians of Canada (CFPC) is the professional organization that represents more than 38,000 members across the country. The College establishes the standards for and accredits postgraduate family medicine training in Canada's 17 medical schools. It reviews and certifies continuing professional development programs and materials that enable family physicians to meet certification and licensing requirements. The CFPC provides high-quality services, supports family medicine teaching and research, and advocates on behalf of the specialty of family medicine, family physicians, and the patients they serve.
About the Foundation for Advancing Family Medicine The CFPC's Foundation for Advancing Family Medicine (FAFM), formerly known as the Research and Education Foundation, was established in 1994 to provide leadership in family medicine through philanthropy. The FAFM funds programs and projects in family medicine and supports numerous research grants, scholarships, and awards that recognize the achievements of clinicians, teachers, researchers, family medicine residents, and medical students. Our funding priorities (family medicine research and family medicine education, the Patient's Medical Home, and global health care via the Besrour Centre) recognize our most important initiatives and have a meaningful impact on improving patient care in Canada and around the world. https://fafm.cfpc.ca.
About the Canadian Medical Association Since 1867, the Canadian Medical Association has been the national voice of Canada's medical profession. We work with physicians, residents and medical students on issues that matter to the profession and the health of Canadians. We advocate for policy and programs that drive meaningful change for physicians and their patients.
SOURCE Scotiabank
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
